Aandelen in “Productie van chirurgische apparatuur”

Aandeel	Datum	Koers	Evolutie
CollPlant Biotechnologies Ltd	3/08	0,318 USD +16,57%	+16,57%

Nieuws over “Productie van chirurgische apparatuur”

Toon enkel gratis nieuws

29/07 · Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation · Persbericht

29/07 · Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation · Persbericht

15/07 · Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons · Persbericht

30/06 · COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT · Persbericht

8/06 · Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty · Persbericht

29/05 · COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE · Persbericht

5/05 · Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe